Secondary prevention of cardiovascular disease in high-risk patients diagnosed with cardiovascular disease (status post myocardial infarction or stroke, peripheral arterial disease), type 2 diabetes, or moderate to severe chronic kidney disease (CKD 4-5): in patients who cannot be diagnosed with FH according to Dutch criteria, although they have lipid disorders and do not achieve their LDL-C targets, according to the adopted guidelines (), and in whom all other standard therapies have failed (for at least 3 months) or are poorly tolerated, and/or there are contraindications to pharmacological treatment (adverse effects, complications, e.g
Es ms habitual a partir de los 50 aos y no contiene melanina
10.6039/j.issn.1001-0408.2023.11.01 114 SjholmA
doi: 10.3389/fmicb.2022.811258 75 ChaturvediRAsimMRomero-GalloJBarryDPHogeSde SabletTet al
NAC works by donating a cysteine molecule to your cells, which they use to synthesize glutathione the antioxidant that protects cell membranes, supports detoxification in your liver, and keeps your immune system running
The difference in effectiveness could be attributed to tirzepatides GIP agonism and its more robust ability to promote weight loss